Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study-Reference-Cited by-同舟云学术

Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-α2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study

Published:2010-01 Issue:1 Volume:57 Page:25-31
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Duchek Miloš,Johansson Robert,Jahnson Staffan,Mestad Oddvar,Hellström Pekka,Hellsten Sverker,Malmström Per-Uno

Publisher

Elsevier BV

Subject

Urology

Reference13 articles.

1. A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder;Raitanen;Br J Urol,1995

2. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008

3. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial;Divrik;J Urol,2006

4. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001;Gardmark;Scand J Urol Nephrol,2006

5. 5-year followup of a randomized prospective study comparing mitomycin C and bacillus Calmette-Guerin in patients with superficial bladder carcinoma. Swedish-Norwegian Bladder Cancer Study Group;Malmström;J Urol,1999

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience of organizing BCG therapy for localized bladder cancer in outpatient cancer care centers;Consilium Medicum;2024-08-30

2. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

3. Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review;Journal of Clinical Medicine;2024-06-27

4. Research progress in the off-target effects of Bacille Calmette–Guérin vaccine;Chinese Medical Journal;2023-12-13

5. Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Guérin–exposed Non–muscle-invasive Bladder Cancer;European Urology Oncology;2023-10